Lichter, Peter 1957-
Peter Lichter
VIAF ID: 12146095357400372637 ( Personal )
Permalink: http://viaf.org/viaf/12146095357400372637
Preferred Forms
- 100 1 _ ‡a Lichter, Peter ‡d 1957-
- 100 0 _ ‡a Peter Lichter
4xx's: Alternate Name Forms (8)
5xx's: Related Names (5)
- 510 2 _ ‡a Deutsche Akademie der Naturforscher Leopoldina ‡4 affi ‡4 https://d-nb.info/standards/elementset/gnd#affiliation ‡e Affiliation
- 551 _ _ ‡a Heidelberg ‡4 ortw ‡4 https://d-nb.info/standards/elementset/gnd#placeOfActivity
- 510 2 _ ‡a Klinikum Heidelberg ‡4 affi ‡4 https://d-nb.info/standards/elementset/gnd#affiliation ‡e Affiliation
- 551 _ _ ‡a Mannheim ‡4 ortg ‡4 https://d-nb.info/standards/elementset/gnd#placeOfBirth
- 510 2 _ ‡a Universität Heidelberg ‡b Medizinische Fakultät ‡4 affi ‡4 https://d-nb.info/standards/elementset/gnd#affiliation ‡e Affiliation
Works
Title | Sources |
---|---|
BCAT1 redox function maintains mitotic fidelity | |
Characterization of the T-cell landscape and its functional role in Chronic Lymphocytic Leukemia | |
Clonal Evolution Dynamics and Tumor Microenvironment Composition of Chronic Lymphocytic Leukemia | |
DNA fragility in murine neural progenitor cells attempts to identify early replicating fragile sites and interrupt transcription activity | |
Elastic SCAD as a novel penalization method for SVM classification tasks in high-dimensional data | |
EOMES and IL-10 regulate antitumor activity of T regulatory type 1 CD4+ T cells in chronic lymphocytic leukemia | |
Evidence for multi-copy Mega-NUMTs in the human genome | |
FACT – a framework for the functional interpretation of high-throughput experiments | |
Matrix-comparative genomic hybridization from multicenter formalin-fixed paraffin-embedded colorectal cancer tissue blocks | |
Screen of Compounds to Target Tumor Cells with Chromothripsis | |
Struktur und Expression genomischer Information für die schwere Kette eines menschlichen Myosins | |
Utilizing gene expression profiling, phosphoproteomics and loss-of-function screens to enhance the therapeutic efficacy of dasatinib in glioblastoma |